Koers Cann American Corp. Other OTC
Aandelen
CNNA
US13764N2071
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 964K 888K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 10 mln. 9,21 mln. | Nettowinst (verlies) 2023 | 3 mln. 2,76 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 202K 186K | Nettoschuld 2023 | 311K 286K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
0,12
x | K/w-verhouding 2023 |
0,19
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 01-02-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 01-02-23 |
Pete Caruso
BRD | Director/Board Member | - | 01-03-23 |
Michael Kramer
BRD | Director/Board Member | - | 10-05-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,74% | 723 mld. | |
+34,26% | 595 mld. | |
-2,07% | 369 mld. | |
+20,25% | 332 mld. | |
+2,99% | 282 mld. | |
+17,23% | 244 mld. | |
+9,70% | 208 mld. | |
-4,79% | 205 mld. | |
+2,81% | 168 mld. |